|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| A61K 31/4353 | |||
| A61K 31/4427 | |||
| C07D 401/04 | |||
| C07D 401/10 | |||
| C07D 471/04 | |||
| C07D 487/04 | |||
| A61P 25/00 |
| (11) | Number of the document | 2922842 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13798625.3 |
| Date of filing the European patent application | 2013-11-25 | |
| (97) | Date of publication of the European application | 2015-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/074532 |
| Date | 2013-11-25 |
| (87) | Number | WO 2014/079995 |
| Date | 2014-05-30 |
| (30) | Number | Date | Country code |
| 201261729877 P | 2012-11-26 | US |
| (72) |
GENESTE, Hervé, DE
TURNER, Sean, DE
OCHSE, Michael, DE
DRESCHER, Karla, DE
BLACK, Lawrence A., US
JANTOS, Katja, DE
JAKOB, Clarissa, DE
|
| (73) |
AbbVie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
AbbVie Deutschland GmbH & Co KG, Max-Planck-Ring 2a, 65205 Wiesbaden, DE |
| (54) | INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A |
| INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A |